Earnings Call · Q1 FY2025·2025-05-01

Q1 25EPS +35.48%·Rev n/aQ4 24EPS +4.17%·Rev n/aQ3 24EPS +18.52%·Rev n/aQ2 24EPS +12.12%·Rev n/a⚠ consensus missing

Adaptive Biotechnologies Corp ADPT

Karina Calzadilla — Head of Investor Relations

Chad Robins — Chief Executive Officer

Kyle Piskel — Chief Financial Officer

0.0%1d on move date−0.7% vs SPY3d+36.3%5d+19.7%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ADPT calls or request research access.

More ADPT calls Browse calls Request research access